Marc Odrich

No más puestos en curso

Fortuna: 2 M $ al 31/05/2024

Consumer Services

Health Technology

Health Services

Cargos activos de Marc Odrich

Empresas	Cargo	Inicio	Fin
TearSolutions, Inc. TearSolutions, Inc. BiotechnologyHealth Technology TearSolutions, Inc. develops natural tear generation therapy for dry eyes. The firm's platform technology focuses on the tear protein 'lacritin'? and the proprietary drug 'Lacripep'?. The company was founded by Mark B. Logan, and Gordon W. Laurie in 2013 and is headquartered in Charlottesville, VA.	Corporate Officer/Principal	-	-
CXL Ophthalmics LLC CXL Ophthalmics LLC Medical/Nursing ServicesHealth Services CXL Ophthalmics LLC develops a treatment for eyecare. The company is based in Encinitas, CA. The CEO of the company is Michael D. Webb.	Director/Miembro de la Junta	-	-
University of Virginia	Corporate Officer/Principal	-	-

Empresas	Cargo	Inicio	Fin
VISX, Inc.	Director Técnico/Científico/I+D	-	-

Columbia University College of Physicians & Surgeons

Doctorate Degree

Internacional

Estados Unidos

Operativa

Corporate Officer/Principal	2
Chief Tech/Sci/R&D Officer	2
Director/Board Member	1

Sectorial

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas privadas	3
TearSolutions, Inc. TearSolutions, Inc. BiotechnologyHealth Technology TearSolutions, Inc. develops natural tear generation therapy for dry eyes. The firm's platform technology focuses on the tear protein 'lacritin'? and the proprietary drug 'Lacripep'?. The company was founded by Mark B. Logan, and Gordon W. Laurie in 2013 and is headquartered in Charlottesville, VA.	Health Technology
VISX, Inc.
CXL Ophthalmics LLC CXL Ophthalmics LLC Medical/Nursing ServicesHealth Services CXL Ophthalmics LLC develops a treatment for eyecare. The company is based in Encinitas, CA. The CEO of the company is Michael D. Webb.	Health Services